Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of an External Erectile Device in Transgender Man Following Phalloplasty (ProstHEsis)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03823014
Recruitment Status : Recruiting
First Posted : January 30, 2019
Last Update Posted : July 1, 2019
Sponsor:
Information provided by (Responsible Party):
Elizabeth Boskey, Boston Children’s Hospital

Brief Summary:
The purpose of this study is to test whether an external erectile prosthesis (The Elator™) is a feasible alternative to internal erectile prostheses for transgender men who have undergone a phalloplasty with glansplasty and wish to use their neophallus for sexual penetration. The Elator™ was initially developed for men experiencing erectile dysfunction after prostate cancer. The device consists of two silicone rings connected by a pair of plastic coated rigid metal rods. One ring goes at the base of the penis. The other ring is connected to the rods. This ring is placed behind the glans, and then the rods are connected to the base ring to stretch and provide rigidity to the phallus.

Condition or disease Intervention/treatment Phase
Transsexualism Surgery Sex Behavior Erectile Dysfunction Device: Elator Not Applicable

Detailed Description:

There are approximately 1.4 million transgender adults in the United States. Approximately half are transgender men, individuals who have a male gender identity but were assigned female at birth. A national survey of transgender adults found more than half of transgender men have had, or may want, gender affirmation surgery in the form of phalloplasty - the surgical creation of a penis and scrotum. The neophallus created in this manner can be used for standing urination but not for penetrative sex, due to the lack of erectile structures.

Research suggests that one factor limiting interest in phalloplasty is the lack of reliable, durable, and desirable erectile devices. Internal prostheses are the primary method used to attain penile rigidity after phalloplasty. However, these devices carry a significant risk of mechanical failure and other adverse events. The high failure and complication rates associated with internal erectile prostheses demonstrate a need for alternative options for transgender men after phalloplasty. One such option consists of an external erectile prosthesis or support. The Elator™ consists of two silicone rings connected by a pair of plastic coated rigid metal rods. Use of such an external device may be preferable for men who do not wish to undergo additional surgery after phalloplasty, and/or those who have had problems with internal prostheses.

Word of mouth suggests that a number of transgender men have experimented with these devices after phalloplasty, but to date no study has tested the safety and function of external erectile prostheses in this population. Currently, the FDA exempts most external penile rigidity devices from pre-market notification and review. As such, safety and efficacy testing is not required prior to public marketing. However, before medical professionals can feel comfortable recommending these devices to their patients, such testing is clearly indicated.

The proposed pilot study will test whether an external erectile prosthesis (The Elator™) is a feasible alternative to internal erectile prostheses for transgender men after phalloplasty. This study will recruit twenty men who have had a phalloplasty greater than one year prior to the study date, have protective sensation to the tip of their phallus, have a current sexual partner with whom they would like to explore sexual penetration using the neophallus, and who do not currently have an internal erectile prosthesis.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Pilot study to determine feasibility of device use for supportive care of transgender patients with erectile concerns post phalloplasty. Device is currently available in market.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Use of an External Erectile Device in Transgender Man Following Phalloplasty
Estimated Study Start Date : July 2019
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : July 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: External Erectile Prosthesis
Study participants will be recruited as couples (transgender man + sexual partner.) Couples will use an external erectile prosthesis (Elator) over the course of 1 month and keep track of their experiences. 20 men and their partners will be enrolled.
Device: Elator
Measurement for device, use of device
Other Name: Erector




Primary Outcome Measures :
  1. Change in Quality of Sexual Experience Scale [ Time Frame: Baseline and at study completion (~1.5 months) ]
    Brief measure of quality of most recent sexual experience

  2. Change in Relationship Satisfaction Subscale [ Time Frame: Baseline and at study completion (~1.5 months) ]
    Measure of overall relationship satisfaction with romantic partner

  3. Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) [ Time Frame: The intervention period of 4 weeks, assessed at study completion ]
    Validated measure of satisfaction with erectile dysfunction treatment


Secondary Outcome Measures :
  1. Qualitative Device Feedback [ Time Frame: The intervention period of 4 weeks, assessed at study completion ]
    Interview with men and their partners about the experience of using the device (optional)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Transgender men and their sexual partners (no gender/sex requirement)
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Primary study subject must have had a phalloplasty with glansplasty a minimum of 1 year before enrollment and must have protective sensation to the tip of the phallus
  • Primary study subject must be in a relationship in which they are having, or would like to have, penetrative sex with their partner. Partner must also be interested in having penetrative sex with primary subject.
  • Both primary study subject and partner must have (individual) e-mail addresses and access to the Internet to complete surveys
  • Primary study subject must be willing to be contacted by postal mail, in order to receive the device
  • Both subjects must be willing to receive e-mails

Exclusion Criteria:

  • Either subject or partner does not speak English
  • Primary subject has an internal erectile prosthesis.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03823014


Contacts
Layout table for location contacts
Contact: Elizabeth Boskey, Ph.D. 617-919-6525 elizabeth.boskey@childrens.harvard.edu
Contact: Divya Jolly, MA divya.jolly@childrens.harvard.edu

Locations
Layout table for location information
United States, Massachusetts
Participation in this study is from participants home. Recruiting
Somerville, Massachusetts, United States, 02145
Contact: Elizabeth R Boskey    617-919-6525    elizabeth.boskey@childrens.harvard.edu   
Sponsors and Collaborators
Boston Children’s Hospital

Layout table for additonal information
Responsible Party: Elizabeth Boskey, Researcher, Boston Children’s Hospital
ClinicalTrials.gov Identifier: NCT03823014     History of Changes
Other Study ID Numbers: IRB-P00029965
First Posted: January 30, 2019    Key Record Dates
Last Update Posted: July 1, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Elizabeth Boskey, Boston Children’s Hospital:
transgender
transmasculine
ftm
phalloplasty
penile prosthesis

Additional relevant MeSH terms:
Layout table for MeSH terms
Erectile Dysfunction
Sexual Dysfunction, Physiological
Genital Diseases, Male
Sexual Dysfunctions, Psychological
Mental Disorders